-
1دورية أكاديمية
المؤلفون: Chen J; Department of Pulmonary Medicine, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, Fujian 361000, People's Republic of China., Chen A; Department of Endocrinology, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian 361000, People's Republic of China., Yang S; Department of Pulmonary Medicine, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, Fujian 361000, People's Republic of China., Liu J; Department of Pulmonary Medicine, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, Fujian 361000, People's Republic of China., Xie C; Department of Pulmonary Medicine, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, Fujian 361000, People's Republic of China. Electronic address: Xiecy10365@163.com., Jiang H; Department of Pulmonary Medicine, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, Fujian 361000, People's Republic of China. Electronic address: Jiang.hongni@zsxmhospital.com.
المصدر: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2024 Jul; Vol. 196, pp. 110325. Date of Electronic Publication: 2024 May 10.
نوع المنشور: Journal Article; Systematic Review; Meta-Analysis; Review
بيانات الدورية: Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8407192 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0887 (Electronic) Linking ISSN: 01678140 NLM ISO Abbreviation: Radiother Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Lung Neoplasms*/genetics , Lung Neoplasms*/diagnostic imaging , Lung Neoplasms*/pathology , Machine Learning* , Mutation* , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/diagnostic imaging, Humans ; Positron Emission Tomography Computed Tomography ; ErbB Receptors/genetics ; Proto-Oncogene Proteins p21(ras)
-
2دورية أكاديمية
المؤلفون: Meng N; Department of Medical Imaging, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, Zhengzhou, China.; Laboratory of Brain Science and Brain-Like Intelligence Technology, Institute for Integrated Medical Science and Engineering, Henan Academy of Sciences, Zhengzhou, China.; Biomedical Research Institute, Henan Academy of Sciences, Zhengzhou, China., Jiang H; Department of Medical Imaging, Xinxiang Medical University People's Hospital & Henan Provincial People's Hospital, Zhengzhou, China., Sun J; Department of Pediatrics, Zhengzhou Central Hospital Affiliated to Zhengzhou University & Zhengzhou Central Hospital, Zhengzhou, China., Shen L; Department of Medical Imaging, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, Zhengzhou, China.; Laboratory of Brain Science and Brain-Like Intelligence Technology, Institute for Integrated Medical Science and Engineering, Henan Academy of Sciences, Zhengzhou, China., Wang X; Department of Medical Imaging, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, Zhengzhou, China.; Laboratory of Brain Science and Brain-Like Intelligence Technology, Institute for Integrated Medical Science and Engineering, Henan Academy of Sciences, Zhengzhou, China., Zhou Y; Department of Medical Imaging, Xinxiang Medical University People's Hospital & Henan Provincial People's Hospital, Zhengzhou, China., Wu Y; Department of Medical Imaging, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, Zhengzhou, China.; Laboratory of Brain Science and Brain-Like Intelligence Technology, Institute for Integrated Medical Science and Engineering, Henan Academy of Sciences, Zhengzhou, China., Fu F; Department of Medical Imaging, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, Zhengzhou, China.; Laboratory of Brain Science and Brain-Like Intelligence Technology, Institute for Integrated Medical Science and Engineering, Henan Academy of Sciences, Zhengzhou, China., Yuan J; Central Research Institute, United Imaging Healthcare Group, Shanghai, China., Yang Y; Beijing United Imaging Research Institute of Intelligent Imaging, United Imaging Healthcare Group, Beijing, China., Wang Z; Central Research Institute, United Imaging Healthcare Group, Shanghai, China., Wang M; Department of Medical Imaging, Henan Provincial People's Hospital & Zhengzhou University People's Hospital, Zhengzhou, China.; Laboratory of Brain Science and Brain-Like Intelligence Technology, Institute for Integrated Medical Science and Engineering, Henan Academy of Sciences, Zhengzhou, China.; Biomedical Research Institute, Henan Academy of Sciences, Zhengzhou, China.
المصدر: Journal of magnetic resonance imaging : JMRI [J Magn Reson Imaging] 2024 Jul; Vol. 60 (1), pp. 125-135. Date of Electronic Publication: 2023 Oct 18.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 9105850 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-2586 (Electronic) Linking ISSN: 10531807 NLM ISO Abbreviation: J Magn Reson Imaging Subsets: MEDLINE
مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/diagnostic imaging , Fluorodeoxyglucose F18* , Lung Neoplasms*/diagnostic imaging , Positron-Emission Tomography*/methods , Magnetic Resonance Imaging*/methods , Progression-Free Survival*, Humans ; Female ; Male ; Middle Aged ; Aged ; Adult ; Aged, 80 and over ; Prospective Studies ; Young Adult ; Protons ; Multimodal Imaging ; Radiopharmaceuticals ; Motion ; Prognosis
-
3دورية أكاديمية
المؤلفون: Wang Q; Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China; Department of Cardiothoracic Vascular Surgery, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, China., Zhang C; Clinical Skills Center, Hubei University of Medicine, Shiyan, Hubei 442000, China., Jiang H; Department of Cardiothoracic Vascular Surgery, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei 442000, China., He W; Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China. Electronic address: Weiyang361@163.com.
المصدر: Gene [Gene] 2024 Jun 30; Vol. 913, pp. 148375. Date of Electronic Publication: 2024 Mar 14.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier/North-Holland Country of Publication: Netherlands NLM ID: 7706761 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0038 (Electronic) Linking ISSN: 03781119 NLM ISO Abbreviation: Gene Subsets: MEDLINE
مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/pathology , Lung Neoplasms*/pathology, Animals ; Mice ; Proto-Oncogene Proteins c-akt/genetics ; Proto-Oncogene Proteins c-akt/metabolism ; Mice, Nude ; Angiogenesis ; Signal Transduction ; TOR Serine-Threonine Kinases/genetics ; TOR Serine-Threonine Kinases/metabolism ; Apoptosis/genetics ; Calcium-Calmodulin-Dependent Protein Kinases ; Autophagy/genetics ; Cell Proliferation ; Cell Line, Tumor
-
4دورية أكاديمية
المؤلفون: Wang D; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center of Cancer Medicine, Guangzhou, Guangdong, China., Liu S; Department of Pathology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center of Cancer Medicine, Guangzhou, Guangdong, China., Fu J; Department of Pathology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center of Cancer Medicine, Guangzhou, Guangdong, China., Zhang P; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center of Cancer Medicine, Guangzhou, Guangdong, China., Zheng S; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center of Cancer Medicine, Guangzhou, Guangdong, China., Qiu B; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center of Cancer Medicine, Guangzhou, Guangdong, China., Liu H; United Imaging Healthcare, ShangHai, China., Ye Y; United Imaging of Healthcare America, Houston, Texas, USA., Guo J; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center of Cancer Medicine, Guangzhou, Guangdong, China., Zhou Y; SuZhou TongDiao Company, Suzhou, China., Jiang H; SuZhou TongDiao Company, Suzhou, China., Yin S; Department of Radiology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center of Cancer Medicine, Guangzhou, Guangdong, China., He H; Department of Radiology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center of Cancer Medicine, Guangzhou, Guangdong, China liuhuisysucc@126.com xiechm@sysucc.org.cn hehq@sysucc.org.cn., Xie C; Department of Radiology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center of Cancer Medicine, Guangzhou, Guangdong, China liuhuisysucc@126.com xiechm@sysucc.org.cn hehq@sysucc.org.cn., Liu H; Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center of Cancer Medicine, Guangzhou, Guangdong, China liuhuisysucc@126.com xiechm@sysucc.org.cn hehq@sysucc.org.cn.
المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Jun 23; Vol. 12 (6). Date of Electronic Publication: 2024 Jun 23.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/therapy , Carcinoma, Non-Small-Cell Lung*/mortality , Carcinoma, Non-Small-Cell Lung*/diagnostic imaging , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/pathology , Chemoradiotherapy*/methods , Lung Neoplasms*/therapy , Lung Neoplasms*/mortality , Lung Neoplasms*/diagnostic imaging , Lung Neoplasms*/drug therapy , Lung Neoplasms*/pathology , Immunotherapy*/methods, Humans ; Female ; Male ; Middle Aged ; Aged ; Adult ; Magnetic Resonance Imaging/methods ; Contrast Media ; Treatment Outcome ; Induction Chemotherapy ; Neoplasm Staging ; Prospective Studies
-
5دورية أكاديمية
المؤلفون: Wang F; Department of Radiology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, China., Yang H; Department of Radiology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, China., Chen W; Department of Radiology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, China., Ruan L; Department of Radiology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, China., Jiang T; Department of Radiology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, China., Cheng L; Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, China., Jiang H; Department of Radiology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, China. Electronic address: jianght@zjcc.org.cn., Fang M; Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, China.
المصدر: Current problems in cancer [Curr Probl Cancer] 2024 Jun; Vol. 50, pp. 101098. Date of Electronic Publication: 2024 May 04.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Mosby Country of Publication: United States NLM ID: 7702986 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-6345 (Electronic) Linking ISSN: 01470272 NLM ISO Abbreviation: Curr Probl Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/pathology , Carcinoma, Non-Small-Cell Lung*/diagnostic imaging , Carcinoma, Non-Small-Cell Lung*/therapy , Carcinoma, Non-Small-Cell Lung*/drug therapy , Lung Neoplasms*/pathology , Lung Neoplasms*/diagnostic imaging , Lung Neoplasms*/therapy , Lung Neoplasms*/drug therapy , Neoadjuvant Therapy*/methods , Tomography, X-Ray Computed*/methods, Humans ; Male ; Female ; Retrospective Studies ; Middle Aged ; Aged ; Immunotherapy/methods ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Prognosis ; Adult ; Radiomics
-
6دورية أكاديمية
المؤلفون: Xie M; Oncology Data Science, AstraZeneca, Waltham, MA, USA., Vuko M; Computational Pathology, AstraZeneca, Munich, Germany., Rodriguez-Canales J; Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA., Zimmermann J; Computational Pathology, AstraZeneca, Munich, Germany., Schick M; Computational Pathology, AstraZeneca, Munich, Germany., O'Brien C; Biostatistics, Oncology R&D, AstraZeneca, Cambridge, UK., Paz-Ares L; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain., Goldman JW; David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Garassino MC; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; The University of Chicago, Chicago, IL, USA., Gay CM; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Heymach JV; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jiang H; Oncology R&D, AstraZeneca, Gaithersburg, MD, USA., Barrett JC; Translational Medicine, AstraZeneca, Waltham, MA, United States., Stewart RA; Translational Medicine, Oncology R&D, AstraZeneca, Cambridge, UK., Lai Z; Oncology Data Science, AstraZeneca, Waltham, MA, USA., Byers LA; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rudin CM; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Shrestha Y; Translational Medicine, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA. yashaswi.shrestha@astrazeneca.com.
المصدر: Molecular cancer [Mol Cancer] 2024 May 30; Vol. 23 (1), pp. 115. Date of Electronic Publication: 2024 May 30.
نوع المنشور: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598 (Electronic) Linking ISSN: 14764598 NLM ISO Abbreviation: Mol Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Small Cell Lung Carcinoma*/drug therapy , Small Cell Lung Carcinoma*/genetics , Small Cell Lung Carcinoma*/pathology , Small Cell Lung Carcinoma*/immunology , Small Cell Lung Carcinoma*/therapy , Small Cell Lung Carcinoma*/metabolism , Small Cell Lung Carcinoma*/mortality , Biomarkers, Tumor* , Lung Neoplasms*/drug therapy , Lung Neoplasms*/pathology , Lung Neoplasms*/mortality , Lung Neoplasms*/genetics , Lung Neoplasms*/immunology , Lung Neoplasms*/therapy , Lung Neoplasms*/metabolism , Immunotherapy*/methods, Humans ; Female ; Male ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Middle Aged ; Aged ; Antibodies, Monoclonal/therapeutic use ; Treatment Outcome ; Neoplasm Staging ; Antibodies, Monoclonal, Humanized/therapeutic use ; Prognosis ; Adult
-
7دورية أكاديمية
المؤلفون: Li F; Department of Tumor Radiotherapy, First Affiliated Hospital of Bengbu Medical University, Bengbu 233004, China., Xiang J; Department of Respiratory and Critical Medicine, First Affiliated Hospital of Bengbu Medical University, Bengbu 233004, China.; Department of Respiratory and Critical Medicine, Qijiang District People's Hospital, Chongqing 401420, China., Liu J; Department of Respiratory and Critical Medicine, First Affiliated Hospital of Bengbu Medical University, Bengbu 233004, China., Wang X; Department of Respiratory and Critical Medicine, First Affiliated Hospital of Bengbu Medical University, Bengbu 233004, China.; Clinical Basis of Respiratory Diseases Key Laboratory of Anhui Province, Bengbu 233004, China., Jiang H; Department of Tumor Radiotherapy, First Affiliated Hospital of Bengbu Medical University, Bengbu 233004, China.
المصدر: Nan fang yi ke da xue xue bao = Journal of Southern Medical University [Nan Fang Yi Ke Da Xue Xue Bao] 2024 May 20; Vol. 44 (5), pp. 841-850.
نوع المنشور: English Abstract; Journal Article
بيانات الدورية: Publisher: Nanfang yi ke da xue xue bao bian ji bu Country of Publication: China NLM ID: 101266132 Publication Model: Print Cited Medium: Print ISSN: 1673-4254 (Print) Linking ISSN: 16734254 NLM ISO Abbreviation: Nan Fang Yi Ke Da Xue Xue Bao Subsets: MEDLINE
مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/metabolism , Carcinoma, Non-Small-Cell Lung*/pathology , Cyclin D1*/metabolism , Cyclin D1*/genetics , Lung Neoplasms*/genetics , Lung Neoplasms*/metabolism , Lung Neoplasms*/pathology , MicroRNAs*/genetics , MicroRNAs*/metabolism , RNA, Long Noncoding*/genetics , RNA, Long Noncoding*/metabolism , Cell Proliferation*/genetics , Cell Movement*/genetics, Humans ; Cell Line, Tumor ; Disease Progression ; DNA-Binding Proteins/genetics ; DNA-Binding Proteins/metabolism ; Neoplasm Invasiveness ; Gene Expression Regulation, Neoplastic ; Repressor Proteins
-
8دورية أكاديمية
المؤلفون: Li N; Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China., Xue D; Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China., Men K; Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China., Li L; Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China., Yang J; Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China., Jiang H; Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China., Meng Q; Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China. mengqw@hrbmu.edu.cn., Zhang S; Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China. zshuai@hrbmu.edu.cn.
المصدر: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2024 May 16; Vol. 32 (6), pp. 358. Date of Electronic Publication: 2024 May 16.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Lung Neoplasms*/drug therapy , Lung Neoplasms*/complications , Malnutrition*/epidemiology , Carcinoma, Non-Small-Cell Lung*/drug therapy, Humans ; Male ; Female ; Middle Aged ; Aged ; Nutrition Assessment ; Nutritional Status ; Antineoplastic Agents/adverse effects ; Quality of Life ; Aged, 80 and over ; Retrospective Studies ; Prevalence ; Adult
-
9دورية أكاديمية
المؤلفون: Xu Y; Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China.; Xiamen Clinical Research Center for Cancer Therapy, Xiamen, China., Zhang Q; Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China.; Xiamen Clinical Research Center for Cancer Therapy, Xiamen, China., Chen Z; Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China.; Xiamen Clinical Research Center for Cancer Therapy, Xiamen, China., Yang S; Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China.; Xiamen Clinical Research Center for Cancer Therapy, Xiamen, China., Chen H; Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China.; Xiamen Clinical Research Center for Cancer Therapy, Xiamen, China., Xiao X; Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China. xiao.xiong@zsxmhospital.com.; Xiamen Clinical Research Center for Cancer Therapy, Xiamen, China. xiao.xiong@zsxmhospital.com., Jiang H; Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China. jiang.hongni@zs-hospital.sh.cn.; Xiamen Clinical Research Center for Cancer Therapy, Xiamen, China. jiang.hongni@zs-hospital.sh.cn.; Zhongshan Hospital, Fudan University, Shanghai, China. jiang.hongni@zs-hospital.sh.cn.; Fudan Zhangjiang Institute, Shanghai, China. jiang.hongni@zs-hospital.sh.cn.
المصدر: BMC pulmonary medicine [BMC Pulm Med] 2024 Apr 12; Vol. 24 (1), pp. 174. Date of Electronic Publication: 2024 Apr 12.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968563 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2466 (Electronic) Linking ISSN: 14712466 NLM ISO Abbreviation: BMC Pulm Med Subsets: MEDLINE
-
10دورية أكاديمية
المؤلفون: Jiang H; Department of General Surgery, Taizhou Central Hospital (Taizhou University, Hospital), Taizhou, China., Li B; Department of Urologic Surgery, Cancer Hospital of China Medical University (Liaoning Cancer Hospital & Institute), Shenyang, China., Wu M; Department of Oncology, The Third People's Hospital of Honghe Prefecture, Gejiu, China., Wang Q; Hunan Academy of Traditional Chinese Medicine, Changsha, China. wangqimei-58@163.com., Li Y; Department of Colorectal and Anorectal Surgery, Hunan Hospital of Integrated Tradmonal Chinese and Western Medicine (Hunan Academy of Traditional Chinese Medicine Affiliated Hospital), Changsha, China. 201670240979@hunnu.edu.cn.
المصدر: BMC cancer [BMC Cancer] 2024 Apr 08; Vol. 24 (1), pp. 428. Date of Electronic Publication: 2024 Apr 08.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE